AuntMinnie 2017: Pull linear MRI contrast from market, European group says
AuntMinnie
OCTOBER 11, 2024
Our top article in 2017 covered an EU regulatory body's controversial recommendation to pull four gadolinium-based contrast agents from the market. The PRAC noted that no clinical diseases or even symptoms have been reported in connection with gadolinium deposition.
Let's personalize your content